|
|
Using game mechanics to improve outcomes among stem cell transplant survivors
|
5R42CA168107-03
|
$344,638
|
$172,319
|
MCLAUGHLIN, JEFFERY
|
RADIANT CREATIVE GROUP, LLC
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$190,647
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$1,800
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$1,125
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$252,285
|
$25,229
|
Fowler, Daniel
|
CCR (NCI)
|
|
|
The Role of NF-kB in B-Cell Differentiation and Lymphomagenesis
|
4R01CA157660-05
|
$331,433
|
$165,717
|
KLEIN, ULF
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S1
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-22S2
|
$202,481
|
$2,025
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
4P30CA060553-22
|
$4,865,180
|
$48,652
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
Targetable Immune Evasion Pathways in Hodgkin Lymphoma
|
2R01CA161026-06
|
$410,899
|
$205,450
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INST
|
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$403,118
|
$100,780
|
Tosato, Giovanna
|
CCR (NCI)
|
|
|
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
|
ZIA BC 011109
|
$174,730
|
$8,737
|
Mitsuya, Hiroaki
|
CCR (NCI)
|
|
|
SPORE in Lymphoma
|
3P50CA126752-10S1
|
$300,703
|
$105,246
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
SPORE in Lymphoma
|
4P50CA126752-10
|
$2,344,258
|
$820,490
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Smartphone for molecular cancer diagnostic in Africa
|
1UH2CA202637-01
|
$491,375
|
$245,688
|
WEISSLEDER, RALPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
SEVERABLE FUNDING FOR NCI-FREDERICK
|
261200800001E
|
$248,730,791
|
$4,463
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
4R01CA170023-04
|
$393,163
|
$196,582
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Research Management and Support
|
RMS ES 2016
|
$320,501,735
|
$20,000
|
N/A
|
National Institutes of Health
|
|
|
Regulation of transcription and tumor suppression by MTG family members
|
5R01CA178030-03
|
$364,000
|
$120,120
|
HIEBERT, SCOTT
|
VANDERBILT UNIVERSITY
|
|
|
Regulation of Exocytosis from Immune Cells
|
ZIA BC 011035
|
$121,947
|
$30,487
|
Roche, Paul
|
CCR (NCI)
|
|
|
Regulation of EBV Latency by EBNA1
|
4R01CA093606-14
|
$329,956
|
$263,965
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
|
Registry linkage projects [including Scandinavia, SEER Medicare, other]
|
ZIA CP010150-10359
|
$17,803
|
$3,561
|
Engels, Eric
|
DCEG (NCI)
|
|
|
Radiation Oncology Branch - Radiation Clinic
|
ZID BC 010990
|
$5,116,524
|
$409,322
|
Camphausen, Kevin
|
CCR (NCI)
|
|
|
Radiation dose- response and second primary cancers of stomach, esophagus, and p
|
ZIA CP010131-04134
|
$79,021
|
$11,853
|
Morton, Lindsay
|
DCEG (NCI)
|
|
|
Preclinical development and clinical monitoring of adoptive immune therapy
|
ZIC BC 011029
|
$441,077
|
$110,269
|
Hakim, Frances
|
CCR (NCI)
|
|
|
Post-Transcriptional Regulation of Interleukin-7 Receptor Expression
|
ZIA BC 011214
|
$560,973
|
$112,195
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
|
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
|
ZIC BC 010548
|
$345,321
|
$69,064
|
Figg, William
|
CCR (NCI)
|
|
|
Optimal Antiretroviral Therapy During Bone Marrow Transplant in HIV-1 Infection
|
5K23CA177321-03
|
$161,608
|
$64,643
|
DURAND, CHRISTINE
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Novel AHCT Regimen for Advanced Hodgkin Lymphoma using Y-90 anti-CD25 with BEAM
|
5R21CA185875-02
|
$174,122
|
$174,122
|
SMITH, EILEEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
|
NCI National Clinical Trials Network-Network Lead Academic Participating Sites
|
5U10CA180836-03
|
$542,404
|
$13,560
|
KINDLER, HEDY
|
UNIVERSITY OF CHICAGO
|
|
|
Natural History Study of the Complications Associated with Allogeneic HCT
|
ZIA BC 011742
|
$369,153
|
$29,532
|
Gea-Banacloche, Juan
|
CCR (NCI)
|
|
|
Molecularly Targeted Therapy for Lymphoma
|
5K24CA184039-03
|
$173,074
|
$34,615
|
GOPAL, AJAY
|
UNIVERSITY OF WASHINGTON
|
|
|
Medical Oncology HIV-AIDS Clinical Research
|
ZID BC 011683
|
$173,361
|
$17,336
|
Gulley, James
|
CCR (NCI)
|
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,305,516
|
$215,276
|
Bilusic, Marijo
|
CCR (NCI)
|
|
|
Mechanisms of transcription factor integration at the c-myc promoter
|
ZIA SC 009144
|
$245,845
|
$24,584
|
Levens, David
|
CCR (NCI)
|
|
|
Lymphoma Studies
|
ZIA SC 006741
|
$536,348
|
$107,270
|
Wilson, Wyndham
|
CCR (NCI)
|
|
|
Lymphoma Disease Discovery and Definition
|
ZIA SC 000550
|
$578,468
|
$57,847
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
In Vivo Model of Epstein-Barr Virus Latency
|
5R01CA073507-18
|
$372,677
|
$186,339
|
LONGNECKER, RICHARD
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
|
Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies
|
ZIA BC 008753
|
$1,657,722
|
$248,658
|
Pastan, Ira
|
CCR (NCI)
|
|
|
Immune Regulatory Roles of Suppressor Of Cytokine Signaling (SOCS) Molecules
|
ZIA BC 011215
|
$240,417
|
$24,042
|
Park, Jung-Hyun
|
CCR (NCI)
|
|
|
Immune reconstitution following autologous and allogeneic stem cell transplant
|
ZIC BC 010934
|
$441,077
|
$88,215
|
Hakim, Frances
|
CCR (NCI)
|
|
|
IL-2:IL-15 cytokine receptor: implications for cancer therapy and vaccine
|
ZIA SC 004002
|
$1,007,184
|
$201,437
|
Waldmann, Thomas
|
CCR (NCI)
|
|
|
Human Immune Responses to Tumor Antigens for Cancer Immunotherapy
|
ZIA BC 010598
|
$534,419
|
$26,721
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
|
Host factors, tumor microenvironment and survival in a multiethnic study of Hodgkin lymphoma patients
|
1R01CA206019-01
|
$735,600
|
$735,600
|
COZEN, WENDY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Hodgkin's families
|
ZIA CP004410-08167
|
$30,637
|
$29,105
|
Goldin, Lynn
|
DCEG (NCI)
|
|
|
HIV AIDS cancer match, U.S.
|
ZIA CP010150-10071
|
$196,073
|
$29,411
|
Engels, Eric
|
DCEG (NCI)
|
|
|
Hematopathology Fellowship
|
ZIE BC 011241
|
$413,192
|
$103,298
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
Hematopathology Diagnosis
|
ZIA BC 011070
|
$661,107
|
$198,332
|
Jaffe, Elaine
|
CCR (NCI)
|
|
|
Familial case-control study of lymphoproliferative malignancies and auto-immune d
|
ZIA CP005803-00355
|
$5,688
|
$1,138
|
Goldin, Lynn
|
DCEG (NCI)
|
|
|
ETIB Clinical Research Core
|
ZID BC 010963
|
$1,047,077
|
$104,708
|
Gress, Ronald
|
CCR (NCI)
|
|
Total relevant funding to Hodgkins disease for this search: $12,769,043
|
